Jul 2026
SYTL4 acts as a tumor suppressor in colorectal cancer by promoting ubiquitination and degradation of SEC31B.
The results delineate the SYTL4-SEC31B axis as a pivotal regulatory pathway in CRC tumorigenesis, which provides a promising candidate therapeutic target for colorectal cancer clinical intervention.
Jin-Lei Li, Xiaodong Zhang, Hongyan Li et al.
· Biochemical and Biophysical... · 0 citations